tiprankstipranks
Insperity Inc (NSP)
NYSE:NSP
Want to see NSP full AI Analyst Report?

Insperity (NSP) AI Stock Analysis

390 Followers

Top Page

NSP

Insperity

(NYSE:NSP)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
$36.00
â–²(24.57% Upside)
Action:ReiteratedDate:05/01/26
The score is held down primarily by weak financial quality—especially the sharp deterioration in operating/free cash flow and the thin, highly levered balance sheet—despite strong recent revenue growth. The earnings call supports a margin-recovery narrative (guidance reiterated and cost/benefit trends improving), while technicals are positive but show overbought risk. Valuation is mixed: an attractive dividend yield is offset by loss-driven negative P/E and cash flow concerns.
Positive Factors
Recurring, scalable PEO business model
Insperity's core PEO structure produces recurring, contractually-linked service fees that scale with client employee counts and payroll. That model creates predictable revenue streams, client stickiness via co-employment, and cross-sell optionality to non‑PEO HR solutions, supporting durable top-line base.
Negative Factors
Severe cash flow deterioration
A large swing to negative operating and free cash flow materially raises liquidity and funding risk. Sustained cash consumption limits the company's ability to invest in tech, absorb benefit volatility, maintain dividends or repurchase shares, and increases reliance on credit facilities during downtimes.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring, scalable PEO business model
Insperity's core PEO structure produces recurring, contractually-linked service fees that scale with client employee counts and payroll. That model creates predictable revenue streams, client stickiness via co-employment, and cross-sell optionality to non‑PEO HR solutions, supporting durable top-line base.
Read all positive factors

Insperity (NSP) vs. SPDR S&P 500 ETF (SPY)

Insperity Business Overview & Revenue Model

Company Description
Insperity, Inc. provides human resources (HR) and business solutions to improve business performance for small and medium-sized businesses. The company offers its HR services through its Workforce Optimization and Workforce Synchronization solutio...
How the Company Makes Money
Insperity generates most of its revenue through its PEO services, where client companies enter a co-employment arrangement and Insperity provides an integrated package of HR-related services. Under this model, Insperity bills clients based largely...

Insperity Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down where Insperity earns sales across regions, highlighting geographic strengths and concentration risk. Regional trends reveal growth opportunities, exposure to local economic cycles or regulatory changes, and where the company’s sales and marketing efforts are most effective.
Chart InsightsInsperity’s revenue recovery is concentrated in the Northeast, but 2025 features a pronounced Q1 spike across regions followed by sequential softening — consistent with a seasonal or one‑time payroll/booking surge rather than durable demand acceleration. Management’s call flags a tepid hiring backdrop and only modest workforce growth, while pricing actions and a UnitedHealthcare agreement should stabilize revenue and blunt benefit-cost pressure; however, margin recovery and sustainable organic expansion remain uncertain given elevated health costs and hiring challenges.
Data provided by:The Fly

Insperity Earnings Call Summary

Earnings Call Date:Apr 30, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Aug 03, 2026
Earnings Call Sentiment Neutral
The call portrayed a company in recovery: solid early progress on margin restoration (improved gross profit trends, controlled operating expenses, improved benefit-cost dynamics) and a promising HRScale rollout and AI strategy that can drive medium-term growth. Offsetting these positives are near-term headwinds—declining worksite employee counts, lower new-sales activity, elevated attrition tied to margin actions, a significant Q1 tax-related EPS hit and seasonal cash pressure. Management maintained full-year adjusted EBITDA guidance but lowered unit guidance, signaling confidence in profitability recovery while acknowledging slower top-line momentum.
Positive Updates
Adjusted EBITDA and EPS Beat Midpoint
Adjusted EPS of $1.31 and adjusted EBITDA of $103 million in Q1 2026 both exceeded the midpoint of guidance; adjusted EBITDA was up 1% versus $102M in Q1 2025.
Negative Updates
Worksite Employee Base Contraction
Average paid worksite employees were 303,049 in Q1 2026, a 1.0% decrease versus Q1 2025; full-year WSE guidance downgraded to 303,000–307,000 (a decline of 1.0%–2.3% vs 2025) and Q2 WSE expected down 1.5%–2.1% YoY.
Read all updates
Q1-2026 Updates
Negative
Adjusted EBITDA and EPS Beat Midpoint
Adjusted EPS of $1.31 and adjusted EBITDA of $103 million in Q1 2026 both exceeded the midpoint of guidance; adjusted EBITDA was up 1% versus $102M in Q1 2025.
Read all positive updates
Company Guidance
Insperity reiterated full‑year adjusted EBITDA guidance of $170M–$230M while trimming unit guidance to 303,000–307,000 average paid worksite employees for 2026 (a 1.0%–2.3% decline vs. 2025) and guiding Q2 WSEs to 302,500–304,500 (down 1.5%–2.1% yoy); full‑year adjusted EPS is $1.60–$2.60 (Q2 $0.02–$0.50) with a FY adjusted tax rate of ~36% and ~38.5M weighted average shares outstanding. In Q1 the company reported adjusted EPS of $1.31 and adjusted EBITDA of $103M, average paid WSEs of 303,049 (‑1.0% vs. Q1 2025), total gross profit of $302M (‑3%), gross profit per WSE of $332/month, benefit cost per covered employee +5% yr/yr (improved from ~9% last year), operating expenses $240M (‑1%; ‑5% ex $9M restructuring), $13M invested in HRScale in Q1 ($8M opex, $5M capex), $36M adjusted cash, $23M dividends paid, 171k shares repurchased for $4M, and ~$380M unused credit capacity (~$330M available); management expects a flatter quarterly earnings pattern due to UnitedHealthcare pooling change ($1M→$500k).

Insperity Financial Statement Overview

Summary
Despite sharp 2025 revenue acceleration, profitability deteriorated (margins compressed and results moved to losses). The balance sheet is thinly capitalized with high leverage (equity down, debt/equity elevated), and cash flow is the biggest weakness with a large swing to negative operating and free cash flow—raising liquidity and funding risk if not reversed.
Income Statement
42
Neutral
Balance Sheet
28
Negative
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.81B6.58B6.49B5.94B4.97B
Gross Profit900.00M1.05B1.04B1.01B820.10M
EBITDA35.00M198.00M295.00M300.29M214.32M
Net Income-7.00M91.00M171.00M179.35M124.08M
Balance Sheet
Total Assets2.20B2.60B2.12B2.04B1.75B
Cash, Cash Equivalents and Short-Term Investments660.00M1.05B709.00M765.90M607.60M
Total Debt435.00M435.00M427.00M424.99M433.59M
Total Liabilities2.16B2.50B2.03B1.96B1.75B
Stockholders Equity46.00M97.00M94.00M81.28M-1.77M
Cash Flow
Free Cash Flow-309.00M482.00M158.37M317.36M227.25M
Operating Cash Flow-278.00M520.00M198.49M347.69M260.15M
Investing Cash Flow-31.00M-38.00M-21.73M-32.12M-31.01M
Financing Cash Flow-90.00M-173.00M-155.01M-141.15M-208.07M

Insperity Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price28.90
Price Trends
50DMA
25.39
Positive
100DMA
32.15
Negative
200DMA
39.85
Negative
Market Momentum
MACD
0.71
Negative
RSI
59.72
Neutral
STOCH
81.59
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NSP, the sentiment is Neutral. The current price of 28.9 is above the 20-day moving average (MA) of 27.06, above the 50-day MA of 25.39, and below the 200-day MA of 39.85, indicating a neutral trend. The MACD of 0.71 indicates Negative momentum. The RSI at 59.72 is Neutral, neither overbought nor oversold. The STOCH value of 81.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NSP.

Insperity Risk Analysis

Insperity disclosed 22 risk factors in its most recent earnings report. Insperity reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Insperity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$3.45B13.7313.94%2.89%5.44%8.92%
65
Neutral
$794.65M16.8723.66%0.88%8.37%4.58%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
57
Neutral
$2.11B4.81185.63%1.81%-1.40%-0.67%
53
Neutral
$1.41B137.58-0.81%4.96%4.77%-115.03%
53
Neutral
$2.72B45.879.98%8.65%-6.08%-35.51%
50
Neutral
$1.36B7.72-7.69%6.37%3.04%-139.52%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NSP
Insperity
28.53
-34.13
-54.46%
BBSI
Barrett Business Services
31.42
-10.22
-24.55%
KFY
Korn Ferry
66.52
4.30
6.91%
MAN
ManpowerGroup
30.52
-11.88
-28.02%
RHI
Robert Half
27.02
-15.08
-35.82%
TNET
TriNet Group
44.47
-34.35
-43.58%

Insperity Corporate Events

Business Operations and StrategyFinancial Disclosures
Insperity Announces Realignment Plan and Workforce Reductions
Negative
Feb 10, 2026
On February 10, 2026, Insperity announced a Realignment Plan that will eliminate about 4% of its non-sales roles as part of an internal reorganization aimed at boosting efficiency and sharpening focus on key business areas, with an estimated $9 mi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 01, 2026